Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer
Breast cancer is one of the leading causes of death for women worldwide. Patients whose tumors express Estrogen Receptor α account for around 70% of cases and are mostly treated with targeted endocrine therapy. However, depending on the degree of severity of the disease at diagnosis, 10 to...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 October 2020
|
| In: |
Cancers
Year: 2020, Jahrgang: 12, Heft: 10 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers12102918 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers12102918 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/12/10/2918 
|
| Verfasserangaben: | Simone Borgoni, Emre Sofyalı, Maryam Soleimani, Heike Wilhelm, Karin Müller-Decker, Rainer Will, Ashish Noronha, Lukas Beumers, Pernette J. Verschure, Yosef Yarden, Luca Magnani, Antoine H. C. van Kampen, Perry D. Moerland and Stefan Wiemann |
Search Result 1
Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer
[2020?]
Buch/Monographie
Hochschulschrift
Search Result 2
Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer
Universitätsbibliothek Heidelberg 2020
Buch/Monographie
Hochschulschrift
Online Resource